These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6426739)

  • 21. [Treatment of refractory heart failure in the advanced phase of congestive myocardiopathy: new positive inotropic and vasodilator drugs].
    Permutti B; Maragno B; Stritoni P; Schivazappa L; Locatelli C
    Boll Soc Ital Cardiol; 1981; 26(1):59-65. PubMed ID: 7340860
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents?
    Cleland JG
    Br J Hosp Med; 1994 Sep 7-20; 52(5):193, 195-6. PubMed ID: 7820314
    [No Abstract]   [Full Text] [Related]  

  • 23. Principles of treatment of left ventricular failure.
    Taylor SH; Silke B; Nelson GI
    Eur Heart J; 1982 Dec; 3 Suppl D():19-43. PubMed ID: 6761126
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of refractory cardiac insufficiency using extracorporeal ultrafiltration].
    Fourati S; Ben Youssef S; Hachicha J; Kharrat M; Daoud M; Jarraya A
    Tunis Med; 1995 May; 73(5):183-7. PubMed ID: 9507281
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug therapy of cardiovascular diseases. Heart failure. Introduction to the subject. Progress since 1982].
    Scholz H
    Z Kardiol; 1992; 81 Suppl 4():15-6. PubMed ID: 1290292
    [No Abstract]   [Full Text] [Related]  

  • 26. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
    Baumann G; Hader O
    Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug therapy of heart failure].
    Follath F
    Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure.
    Elkayam U; Tasissa G; Binanay C; Stevenson LW; Gheorghiade M; Warnica JW; Young JB; Rayburn BK; Rogers JG; DeMarco T; Leier CV
    Am Heart J; 2007 Jan; 153(1):98-104. PubMed ID: 17174645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic therapies for acutely decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2002; 3 Suppl 4():S18-27. PubMed ID: 12439427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P; Ramaprasad S
    Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG; Nikitin N; McGowan J
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathophysiologic rationales for clinical management of heart failure].
    Sasayama S
    Masui; 1994 Oct; 43 Suppl():S35-43. PubMed ID: 7853665
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of heart failure with vasodilators].
    Bolte HD
    Internist (Berl); 1980 Dec; 21(12):753-9. PubMed ID: 6451599
    [No Abstract]   [Full Text] [Related]  

  • 35. Inodilators: a new strategy in the therapy of heart failure. Proceedings of a symposium held during the 24th National Congress of the Italian Society for Pharmacology. Brescia, Italy, September 28, 1988.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S1-132. PubMed ID: 2483433
    [No Abstract]   [Full Text] [Related]  

  • 36. Inotropic agents improve the peripheral microcirculation of patients with end-stage chronic heart failure.
    Nanas S; Gerovasili V; Dimopoulos S; Pierrakos C; Kourtidou S; Kaldara E; Sarafoglou S; Venetsanakos J; Roussos C; Nanas J; Anastasiou-Nana M
    J Card Fail; 2008 Jun; 14(5):400-6. PubMed ID: 18514932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of heart failure in children].
    Pipitone S; Manetti A
    G Ital Cardiol; 1995 Nov; 25(11):1485-90. PubMed ID: 8682250
    [No Abstract]   [Full Text] [Related]  

  • 38. Congestive cardiomyopathy: therapeutic approach.
    Chatterjee K; Stern L
    Compr Ther; 1982 Jul; 8(7):25-34. PubMed ID: 7116806
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hemodynamic effects of ARL 115 in left ventricular insufficiency].
    Drobinski G; Komajda M; Lechat P
    Ann Cardiol Angeiol (Paris); 1984 Nov; 33(7):475-9. PubMed ID: 6508198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug therapy for congestive heart failure poses several risks during dental treatment.
    Biron CR
    RDH; 1996 Feb; 16(2):46-8, 50, 64. PubMed ID: 9442754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.